Ayala Pharmaceuticals
1D
1W
1M
3M
1Y
5Y
Why Robinhood?
You can watch AYLA and buy or sell other stocks, options, and ETFs commission-free!About AYLA
Ayala Pharmaceuticals is a clinical-stage oncology company focused on developing and commercializing small molecule therapeutics for patients suffering from rare and aggressive cancers, primarily in genetically defined patient populations. Ayala’s approach is focused on predicating, identifying and addressing tumorigenic drivers of cancer through a combination of its bioinformatics platform and next-generation sequencing to deliver targeted therapies to underserved patient populations.
CEOKen Berlin
CEOKen Berlin
Employees35
Employees35
HeadquartersRehovot, Tel Aviv
HeadquartersRehovot, Tel Aviv
Founded2017
Founded2017
Employees35
Employees35
AYLA Key Statistics
Market cap7.20M
Market cap7.20M
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume63.91K
Average volume63.91K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$7.13
52 Week high$7.13
52 Week low$0.3568
52 Week low$0.3568
AYLA Earnings
-$0.75
-$0.50
-$0.25
$0.00
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Q4 FY22
Estimated— per share
Estimated— per share
ActualExpected Mar 27, After Hours
ActualExpected Mar 27, After Hours